XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenues:      
Total revenues $ 6,267,411 $ 5,906,956 $ 5,475,846
Costs and expenses:      
Cost of services and product development 2,023,022 1,903,240 1,693,771
Selling, general and administrative 2,884,814 2,701,542 2,480,944
Depreciation 112,083 98,645 93,410
Amortization of intangibles 90,232 92,458 98,536
Acquisition and integration charges 973 9,587 9,079
Gain from sale of divested operation 0 (135,410) 0
Total costs and expenses 5,111,124 4,670,062 4,375,740
Operating income 1,156,287 1,236,894 1,100,106
Interest income 61,558 38,526 4,880
Interest expense (131,046) (132,772) (126,203)
Gain on event cancellation insurance claims 300,000 3,077 0
Other income, net 575 1,404 48,412
Income before income taxes 1,387,374 1,147,129 1,027,195
Provision for income taxes 133,659 264,663 219,396
Net income $ 1,253,715 $ 882,466 $ 807,799
Net income per share:      
Basic (in dollars per share) $ 16.12 $ 11.17 $ 10.08
Diluted (in dollars per share) $ 16.00 $ 11.08 $ 9.96
Weighted average shares outstanding:      
Basic (in shares) 77,785 79,004 80,178
Diluted (in shares) 78,338 79,680 81,067
Research      
Revenues:      
Total revenues $ 5,125,650 $ 4,887,046 $ 4,604,791
Conferences      
Revenues:      
Total revenues 583,224 505,164 389,273
Consulting      
Revenues:      
Total revenues $ 558,537 $ 514,746 $ 481,782